CLINICAL_TRIALS
trial_result
· 2012-06-15
Clinical Trial Update: AMD 3100 for Treatment of Myelokathexis [Phase 1]
Summary
A Phase 1 trial of AMD 3100 (plerixafor) for neutropenia in WHIM syndrome (myelokathexis); results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Washington | Conditions: Neutropenia | Phase 1 | Status: COMPLETED | Results posted: 2012-06-15